Canlitinib

Customer Review

Based on 1 Customer Validation

Canlitinib is a tyrosine kinase inhibitor, extracted from patent WO2018072614 (IV-2). Canlitinib has the potential for cancer study.

For research use only. We do not sell to patients.

  • Purity: 97.09%
  • CAS No.: 2222730-78-9
  • Formula: C33H31F2N3O7
  • Molecular Weight:619.61
  • Storage:

    -20°C, protect from light, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00